arznei-telegramm Logo a-t Kurzlogo
    ❮ a-t 12/2011 a-t ❯
    This is a translation of the table of contents. One article of each issue is translated and freely available.
    table of contents
    SPOT ON

    Dabigatran (PRADAXA) for atrial fibrillation: Does benefit outweigh the risk?

    NEW ON THE MARKET

    Telaprevir (INCIVO) against chronic hepatitis C

    THERAPY FROM A CRITICAL VIEWPOINT

    Letrozole (FEMARA, generics) in the adjuvant treatment of breast cancer

    a-t READER'S QUESTIONS AND COMMENTS

    Stinking rebate drugs

    IN BRIEF

    Approval of bevacizumab (AVASTIN) for breast cancer revoked in the USA and Canada

    Tablet-splitting methods compared

    SIDE EFFECTS

    Risk of thromboembolism with drospirenone (e.g. YASMIN)

    CURRENT ADR NETWORK REPORT

    When the pneumococcal conjugate vaccine PREVENAR 13 flocculates

    Cave: erroneous INR measurement due to dabigatran (PRADAXA)
    free

    arznei-telegramm

    Independent drug information – in English

    Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

    Browse free articles